technetium tc 99m pentetate has been researched along with Meningeal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barth, A; Godoy, N; Haldemann, AR; Kinser, JA; Reubi, JC; Rösler, H; Seiler, RW | 1 |
Colandrea, J; Copeland, C; Dedrick, RL; DeVroom, HL; Greenfield, L; Groves, ES; Houston, LL; Katz, D; Laske, DW; Muraszko, KM; Oldfield, EH; Simon, TR; Sung, C; Youle, RJ | 1 |
1 trial(s) available for technetium tc 99m pentetate and Meningeal Neoplasms
Article | Year |
---|---|
Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cerebral Ventricles; Female; Half-Life; Humans; Immunotoxins; Infusions, Parenteral; Melanoma; Meningeal Neoplasms; Metabolic Clearance Rate; Mice; Middle Aged; Pilot Projects; Receptors, Transferrin; Recombinant Proteins; Ricin; Spinal Cord Neoplasms; Technetium Tc 99m Pentetate | 1997 |
1 other study(ies) available for technetium tc 99m pentetate and Meningeal Neoplasms
Article | Year |
---|---|
Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Diagnosis, Differential; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Octreotide; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Technetium Tc 99m Pentetate | 1996 |